Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population"
-
- Kawasaki, Aya
- 作成者
-
- Sada, Ken-Ei
- 作成者
-
- Hirano, Fumio
- 作成者
-
- Nagasaka, Kenji
- 作成者
-
- Ono, Nobuyuki
- 作成者
-
- Kusaoi, Makio
- 作成者
-
- Tamura, Naoto
- 作成者
-
- Itoh, Kenji
- 作成者
-
- Sumida, Takayuki
- 作成者
-
- Makino, Hirofumi
- 作成者
メタデータ
- 公開日
- 2023-01-01
- DOI
-
- 10.6084/m9.figshare.21876159
- 10.6084/m9.figshare.21876159.v2
- 10.6084/m9.figshare.21876159.v3
- 10.6084/m9.figshare.21876159.v1
- 公開者
- figshare
- データ作成者 (e-Rad)
-
- Kawasaki, Aya
- Sada, Ken-Ei
- Kusumawati, Premita Ari
- Hirano, Fumio
- Kobayashi, Shigeto
- Nagasaka, Kenji
- Sugihara, Takahiko
- Ono, Nobuyuki
- Fujimoto, Takashi
- Kusaoi, Makio
- Tamura, Naoto
- Kusanagi, Yasuyoshi
- Itoh, Kenji
- Sumida, Takayuki
- Yamagata, Kunihiro
- Hashimoto, Hiroshi
- Makino, Hirofumi
- Arimura, Yoshihiro
- Harigai, Masayoshi
- Tsuchiya, Naoyuki
説明
Supplementary Table S1. Association analysis of each HLA-DRB1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S2. Association analysis of each HLA-DQA1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S3. Association analysis of each HLA-DQB1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S4. Association analysis of each HLA-DPB1 allele with occurrence of relapse and time to relapse. Supplementary Table S5 Association analyses of HLA-DRβ1_13S encoding alleles with susceptibility and relapse-free survival. Supplementary Figure S1. Sanger sequencing chromatograms around the HLA-DQA1*03:02 tagSNP rs11545686. Representative Sanger sequencing chromatograms corresponding to each of the three genotypes are shown. The rs11545686C allele tags HLA-DQA1*03:02. HLA-DQA1 genotype of each subject determined by PCR-SSOP was DQA1*03:02/03*02 (relapse ID 36), DQA1*03:02/05:07 (relapse ID 156) and DQA1* 01:01/01:02 (relapse ID 164), as shown in Supplementary Data 1. <br> Supplementary Data 1. Clinical information and HLA genotypes in each subject examined for susceptibility and relapse. <br> Susceptibility Data 2. Association of each HLA -class II amino acid with relapse-free survival. <br>